57 related articles for article (PubMed ID: 31192530)
1. The assessment of 8th edition AJCC prognostic staging system and a simplified staging system for breast cancer: The analytic results from the SEER database.
Zhang J; Zhao B; Jin F
Breast J; 2019 Sep; 25(5):838-847. PubMed ID: 31192530
[TBL] [Abstract][Full Text] [Related]
2. Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System.
Chavez-MacGregor M; Mittendorf EA; Clarke CA; Lichtensztajn DY; Hunt KK; Giordano SH
Oncologist; 2017 Nov; 22(11):1292-1300. PubMed ID: 28592619
[TBL] [Abstract][Full Text] [Related]
3. A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer.
Xu L; Li JH; Ye JM; Duan XN; Cheng YJ; Xin L; Liu Q; Zhou B; Liu YH
Chin Med J (Engl); 2017 Aug; 130(16):1945-1952. PubMed ID: 28776547
[TBL] [Abstract][Full Text] [Related]
4. A retrospective prognostic evaluation analysis using the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system for luminal A breast cancer.
Ye J; Wang W; Xu L; Duan X; Cheng Y; Xin L; Zhang H; Zhang S; Li T; Liu Y
Chin J Cancer Res; 2017 Aug; 29(4):351-360. PubMed ID: 28947867
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Pathological Prognostic Stage and Anatomic Stage Groups According to the Updated Version of the American Joint Committee on Cancer (AJCC) Breast Cancer Staging 8th Edition.
Ibis K; Ozkurt S; Kucucuk S; Yavuz E; Saip P
Med Sci Monit; 2018 May; 24():3637-3643. PubMed ID: 29849016
[TBL] [Abstract][Full Text] [Related]
6. Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology.
Mittendorf EA; Chavez-MacGregor M; Vila J; Yi M; Lichtensztajn DY; Clarke CA; Giordano SH; Hunt KK
Ann Surg Oncol; 2017 Nov; 24(12):3502-3509. PubMed ID: 28726077
[TBL] [Abstract][Full Text] [Related]
7. Stage-Specific Survival Rate of Breast Cancer Patients in Northern Thailand in Accordance with Two Different Staging Systems.
Chitapanarux I; Sripan P; Somwangprasert A; Charoentum C; Onchan W; Watcharachan K; Wongmaneerung P; Kongmebhol P; Jia-Mahasap B; Huntrakul L
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2699-2706. PubMed ID: 31554366
[TBL] [Abstract][Full Text] [Related]
8. Validation of the AJCC 8th Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01).
Krecko LK; Neuman HB; Greenberg CC; Wilke LG; Hanlon BM; Edge SB; Ruddy KJ; Partridge AH; Le-Rademacher J; Yang DY; Havlena J; R Schumacher J
Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38825628
[TBL] [Abstract][Full Text] [Related]
9. Validation of CPS+EG, Neo-Bioscore, and modified Neo-Bioscore staging systems after preoperative systemic therapy of breast cancer: Protocol of a retrospective multicenter cohort study in China.
Xu L; Zhang Z; Liu Q; Zhou B; Liu Y; Xiang Q; Zhu S; Duan X; Cui Y
Thorac Cancer; 2018 Nov; 9(11):1565-1572. PubMed ID: 30296013
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of biologic factors for the staging of de novo stage IV breast cancer.
He ZY; Lian CL; Wang J; Lei J; Hua L; Zhou J; Wu SG
NPJ Breast Cancer; 2020; 6():43. PubMed ID: 32964117
[TBL] [Abstract][Full Text] [Related]
11. Combination of carcinoembryonic antigen with the American Joint Committee on Cancer TNM staging system in rectal cancer: a real-world and large population-based study.
Liu Q; Lian P; Luo D; Cai S; Li Q; Li X
Onco Targets Ther; 2018; 11():5827-5834. PubMed ID: 30271165
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the relationship between Ki67 expression level and neoadjuvant treatment response and prognosis in breast cancer based on the Neo-Bioscore staging system.
Sullu Y; Tomak L; Demirag G; Kuru B; Ozen N; Karagoz F
Discov Oncol; 2023 Oct; 14(1):190. PubMed ID: 37875716
[TBL] [Abstract][Full Text] [Related]
13. Competing risk analysis of cardiovascular death in breast cancer: evidence from the SEER database.
He J; Wang S; Liu H; Duan C; Zhang H; Wen F; Zhang C
Transl Cancer Res; 2023 Dec; 12(12):3591-3603. PubMed ID: 38192997
[TBL] [Abstract][Full Text] [Related]
14. Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. Population.
Zhou Z; Kinslow CJ; Hibshoosh H; Guo H; Cheng SK; He C; Gentry MS; Sun RC
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30769905
[TBL] [Abstract][Full Text] [Related]
15. The Modified Neo-Bioscore System for Staging Breast Cancer Treated with Neoadjuvant Therapy Based on Prognostic Significance of HER2-Low Expression.
Zhao Y; Chen X; Wang Y; Zhang X; Lu J; Yin W
J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610617
[No Abstract] [Full Text] [Related]
16. Establishment of a staging system for visceral sarcoma.
Wang B; Xu L; Fang M; Zheng B; Yan W
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38102873
[TBL] [Abstract][Full Text] [Related]
17. The impact of the Polish mass breast cancer screening program on prognosis in the Pomeranian Province.
Woźniacki P; Skokowski J; Bartoszek K; Kosowska A; Kalinowski L; Jaśkiewicz J
Arch Med Sci; 2017 Mar; 13(2):441-447. PubMed ID: 28261300
[TBL] [Abstract][Full Text] [Related]
18. A Prognostic Model Based on Nutritional Risk Index in Operative Breast Cancer.
Lin F; Xia W; Chen M; Jiang T; Guo J; Ouyang Y; Sun H; Chen X; Deng W; Guo L; Lin H
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145159
[TBL] [Abstract][Full Text] [Related]
19. Novel Signatures Based on the Lymphocyte-to-C-Reactive Protein Ratio Predict the Prognosis of Patients with Early Breast Cancer: A Retrospective Study.
Wang L; Zhang YL; Jiang C; Duan FF; Yuan ZY; Huang JJ; Bi XW
J Inflamm Res; 2022; 15():3957-3974. PubMed ID: 35860229
[TBL] [Abstract][Full Text] [Related]
20. Pan-Immune-Inflammation Value: A New Prognostic Index in Operative Breast Cancer.
Lin F; Zhang LP; Xie SY; Huang HY; Chen XY; Jiang TC; Guo L; Lin HX
Front Oncol; 2022; 12():830138. PubMed ID: 35494034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
